Tap to start →
Photo: Alexander Grey / Unsplash
1 / 3
A biosimilar is an FDA-approved copy of a biologic medicine, such as insulin, that is highly similar to the original with no meaningful clinical differences.
2 / 3
Biologics are large, complex molecules, usually proteins made in living cells.
3 / 3
The biosimilar and generic paths explain which GLP-1 copies are possible and when they might arrive.
A biosimilar is an FDA-approved copy of a biologic medicine, such as insulin, that is highly similar to the original with no meaningful clinical difference
Tap below for the full page. Not medical advice; talk to your clinician about your care.